Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
09/2003
09/11/2003US20030170657 Protein; inducting antibodies; gene expression; diagnosis, vaccines
09/11/2003US20030170653 Using genetic engineered enzyme
09/11/2003US20030170634 Polynucleotide encoding amylase; hydrolysis of starch
09/11/2003US20030170628 Forsenic analysis; medical diagnosis; chromosome markers
09/11/2003US20030170622 Generation of specific binding partners binding to (poly)peptides encoded by genomic dna fragments or ests
09/11/2003US20030170620 Gene controlling androgen
09/11/2003US20030170616 Diagnosis using antibodies; genetic engineering
09/11/2003US20030170270 Nucleic acid encoding an infectious, nonpathogenic PCV1, which contains an immunogenic open reading frame gene of a pathogenic PCV2 in place of an ORF gene of the PCV1 nucleic acid molecule.
09/11/2003US20030170263 Expression system
09/11/2003US20030170259 Chlamydia antigens and corresponding dna fragments and uses thereof
09/11/2003US20030170253 Useful in stimulating angiogenesis as well as in diagnostic applications.
09/11/2003US20030170248 Constant region contains a human immunoglobulin and variable region contains a non-human immunoglobulin variable region; especially treating an infection caused by Enterohemorrhagic Escherichia coli
09/11/2003US20030170243 Use of human plasma hyaluronidase in cancer treatment
09/11/2003US20030170234 Combination of the antibody and a chemotherapeutic agent other than an anthracycline, e.g. doxorubicin or epirubicin; treating cancer
09/11/2003US20030170233 Treating Autoimmune Diseases with Humanized Anti-CD40L Antibody
09/11/2003US20030170228 Compositions and methods for the treatment of tumor
09/10/2003EP1342795A2 Method of detecting a variant of gh1 as indicator of growth hormone dysfunction
09/10/2003EP1342730A1 Fusion protein having the enhanced in vivo activity of erythropoietin
09/10/2003EP1342729A2 Antibodies and antisense molecules for G-coupled receptor showing selective affinity for ATP
09/10/2003EP1342727A1 Antibody against norwalk virus and method of detecting virus by using the antibody
09/10/2003EP1342476A2 FGFR3 as a marker for mesenchymal skeletal progenitor cells and use of cytotoxic conjugates comprising an FGFR3 binding agent for the treatment of cartilagineous bony tumours
09/10/2003EP1341921A2 Hydrolases
09/10/2003EP1341912A2 Combinatorial libraries of proteins having the scaffold structure of c-type lectin-like domains
09/10/2003EP1341899A2 Bacterial host strains
09/10/2003EP1341820A2 Monoclonal antibodies to human immunodeficiency virus and uses thereof
09/10/2003EP1341818A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/10/2003EP1341817A2 Tff peptides
09/10/2003EP1341814A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/10/2003EP1341811A2 Orally ingestible preparation of mistletoe lectins and method
09/10/2003EP1341807A2 Interferon-alpha induced gene
09/10/2003EP1341802A1 In vitro protein synthesis using glycolytic intermediates as an energy source
09/10/2003EP1341792A2 Amido ether substituted imidazoquinolines
09/10/2003EP1341791A2 Thioether substituted imidazoquinolines
09/10/2003EP1341790A2 Sulfonamido ether substituted imidazoquinolines
09/10/2003EP1341789A2 Aryl ether substituted imidazoquinolines
09/10/2003EP1341553A1 Silensed anti-cd28 antibodies and use thereof
09/10/2003EP1007632A4 Isolation of bone and cartilage precursor cells
09/10/2003EP0914613B1 Dp and e2f protein nuclear localisation signals and their use
09/10/2003EP0871763A4 Method for preparation of type ii collagen
09/10/2003EP0736106B1 Methods of screening for beta-amyloid peptide production inhibitors
09/10/2003EP0654092B1 Method for detecting pre-cancerous or cancerous cells using p90 and p53 antibodies or probes
09/10/2003EP0594732B1 Humanized antibody against cd18
09/10/2003EP0575546B1 Cyclin d1 and its cdna
09/10/2003CN1441844A Variable region of monoclonal antibody against HBV s-surface antigen and gene encoding same
09/10/2003CN1441811A Anti-body capable to selectively detect prion PrPsc isoforms
09/10/2003CN1441810A Soluble CTL A4 mutant molecules and use thereof
09/10/2003CN1441808A Chemokine receptor modulators, production and use
09/10/2003CN1441807A Hepatitis B core antigen fusion proteins
09/10/2003CN1441703A Microreactor
09/10/2003CN1441675A Compositions and methods for achieving immune suppression
09/10/2003CN1441058A Prepn process of gene recombining salmon calcitonin
09/10/2003CN1440983A Human thymosin alpha-protothymulin fusion protein and its prepn and use
09/10/2003CN1440980A Mannosan peptide and its prepn and use
09/09/2003US6617450 P-glycoproteins and uses thereof
09/09/2003US6617434 Isolated antibody which binds selectively to tsp50 (testes-specific protease) protein of given amino acid sequence; use in diagnosis and treatment of breast cancer
09/09/2003US6617432 Useful as markers in diagnosing, monitoring the stage of malignancy and treating prostate cancer
09/09/2003US6617431 Recombinant collagen and derived proteins produced by plants, methods for obtaining them and uses
09/09/2003US6617430 Ataxin-2 binding proteins
09/09/2003US6617429 Apoptosis inhibitory protein, gene encoding the protein and cDNA thereof
09/09/2003US6617428 Immunoglobulin M(IgM); given amino acid sequence; immunomodulators; use in blocking or inhibiting humoral immune responses in transplant patients
09/09/2003US6617424 Undecapeptides containing cysteinesulfinic and cysteinesulfenic acid
09/09/2003US6617145 Enzymatic protein for use in treatment of thrombosis
09/09/2003US6617135 Multiple cytokine protein complexes
09/09/2003US6617134 Dimer of molecular variant of apolipoprotein and processes for the production thereof
09/09/2003US6617129 Isolated nucleic acid; prostate-specific gene therapy method; diagnosis and treatment of prostate cancer
09/09/2003US6617120 Nuclear receptor for use as tool in human therapeutics and diagnostics
09/09/2003US6617118 Monoclonal antibody for analysis and clearance of polyethylene glycol and polyethylene glycol-modified molecules
09/09/2003US6617110 Cultured cell comprising a nucleic acid sequence, encoding the protein, that hybridizes to a polynucleotide of given sequence; use to determine if drug is cytotoxic; can use as anticarcinogenic agent
09/09/2003US6617103 Detecting the presence of hybridized nucleic acid; use for diagnosis and treatment of genital cancer
09/09/2003US6617102 Screening for a bioactive agent capable of interfering with the binding of a protein; use in diagnosis and treatment of cancer
09/09/2003US6616930 Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation method
09/04/2003WO2003089641A2 Dual condensation/epimerization domain in non-ribosomal peptide synthetase systems
09/04/2003WO2003073350A2 Method and analytical system for identifying targets in a signaling network
09/04/2003WO2003073238A2 Computational method for designing enzymes for incorporation of amino acid analogs into proteins
09/04/2003WO2003073107A2 Neuropeptide receptor and uses thereof
09/04/2003WO2003072796A1 Reaction solution for cell-free protein synthesis, method of preparing the same and protein synthesis method using the same
09/04/2003WO2003072766A1 Anti-ccr5 antibody
09/04/2003WO2003072751A2 Expression system for human brain-specific voltage-gated sodium channel, type 1
09/04/2003WO2003072743A2 Method for the recombination of genetic elements
09/04/2003WO2003072742A2 Novel glucose 6-oxidases
09/04/2003WO2003072740A2 Novel type-1 cytokine receptor glm-r
09/04/2003WO2003072739A2 Trans-splicing mediated imaging of gene expression
09/04/2003WO2003072736A2 Reagents and treatment methods for autoimmune diseases
09/04/2003WO2003072714A2 Follistatin domain containing proteins
09/04/2003WO2003072698A2 Surface proteins of leptospira
09/04/2003WO2003072609A1 Tick chitinase
09/04/2003WO2003072608A1 Anti-human tenascin monoclonal antibody
09/04/2003WO2003072601A1 Method for producing hypoallergenic major birch pollen allergens rbet v 1
09/04/2003WO2003072062A2 Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders
09/04/2003WO2003072037A2 High-level production of amyloid-beta peptides from imr-32 cells
09/04/2003WO2003072036A2 Treatment methods using anti-cd22 antibodies
09/04/2003WO2003072035A2 Compositions and methods for the treatment of immune related diseases
09/04/2003WO2003072014A2 Minicell compositions and methods
09/04/2003WO2003071877A1 Compositions and methods for eliciting an immune response to gram-negative bacterial infections
09/04/2003WO2003046566A3 Pedf biopolymer markers predictive of alzheimers disease
09/04/2003WO2003046003A3 Plasma protease c1 biopolymer markers predictive of alzheimers disease
09/04/2003WO2003045991A3 Complement c3 precursor biopolymer markers predictive of alzheimers disease
09/04/2003WO2003044187A3 Emulsion compositions
09/04/2003WO2003029423A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/04/2003WO2003028625A3 Methods for screening monoclonal antibodies on heterogeneous antigen substrates
1 ... 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 ... 1125